Related Experiment Video
Updated: May 4, 2026

05:57
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
Published on: August 2, 2022
4.7K
Plasma-derived medicinal products in Italy: information sources and flows
Monica Lanzoni1, Claudia Biffoli2, Fabio Candura3
1Italian National Blood Centre, National Institute of Health, Rome, Italy IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
Blood Transfusion = Trasfusione Del Sangue
|December 17, 2013
Abstract
No abstract available in PubMed .
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
Bioequivalence studies: Biowaivers
430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430

